PMC:1283364 / 21595-21846 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T6618 0-251 sentence denotes Compared to a standard APP transgenic line used for previous amyloid studies by our laboratory (line C3–3; [15,26,27]), we estimated that the four controllable lines produce transgenic APP protein at 10- to 30-fold over endogenous levels (Figure S1).
T6619 1-9 VBN denotes Compared
T6621 10-12 IN denotes to
T6622 13-14 DT denotes a
T6624 15-23 JJ denotes standard
T6625 24-27 NN denotes APP
T6626 28-38 JJ denotes transgenic
T6623 39-43 NN denotes line
T6627 44-48 VBN denotes used
T6628 49-52 IN denotes for
T6629 53-61 JJ denotes previous
T6631 62-69 NN denotes amyloid
T6630 70-77 NNS denotes studies
T6632 78-80 IN denotes by
T6633 81-84 PRP$ denotes our
T6634 85-95 NN denotes laboratory
T6635 96-97 -LRB- denotes (
T6637 97-101 NN denotes line
T6638 102-104 NN denotes C3
T6639 104-105 HYPH denotes
T6640 105-106 CD denotes 3
T6641 106-107 : denotes ;
T6642 108-109 -LRB- denotes [
T6643 109-111 CD denotes 15
T6644 111-112 , denotes ,
T6645 112-114 CD denotes 26
T6646 114-115 , denotes ,
T6636 115-117 CD denotes 27
T6647 117-118 -RRB- denotes ]
T6648 118-119 -RRB- denotes )
T6649 119-121 , denotes ,
T6650 121-123 PRP denotes we
T6620 124-133 VBD denotes estimated
T6651 134-138 IN denotes that
T6653 139-142 DT denotes the
T6655 143-147 CD denotes four
T6656 148-160 JJ denotes controllable
T6654 161-166 NNS denotes lines
T6652 167-174 VBP denotes produce
T6657 175-185 JJ denotes transgenic
T6659 186-189 NN denotes APP
T6658 190-197 NN denotes protein
T6660 198-200 IN denotes at
T6661 201-203 CD denotes 10
T6662 203-204 HYPH denotes -
T6663 205-207 IN denotes to
T6664 208-215 RB denotes 30-fold
T6665 216-220 IN denotes over
T6666 221-231 JJ denotes endogenous
T6667 232-238 NNS denotes levels
T6668 239-240 -LRB- denotes (
T6670 240-246 NN denotes Figure
T6669 247-249 NN denotes S1
T6671 249-250 -RRB- denotes )
T6672 250-251 . denotes .
R4069 T6619 T6620 prep Compared,estimated
R4070 T6621 T6619 prep to,Compared
R4071 T6622 T6623 det a,line
R4072 T6623 T6621 pobj line,to
R4073 T6624 T6623 amod standard,line
R4074 T6625 T6623 nmod APP,line
R4075 T6626 T6623 amod transgenic,line
R4076 T6627 T6623 acl used,line
R4077 T6628 T6627 prep for,used
R4078 T6629 T6630 amod previous,studies
R4079 T6630 T6628 pobj studies,for
R4080 T6631 T6630 compound amyloid,studies
R4081 T6632 T6630 prep by,studies
R4082 T6633 T6634 poss our,laboratory
R4083 T6634 T6632 pobj laboratory,by
R4084 T6635 T6636 punct (,27
R4085 T6636 T6627 parataxis 27,used
R4086 T6637 T6638 compound line,C3
R4087 T6638 T6636 dep C3,27
R4088 T6639 T6638 punct –,C3
R4089 T6640 T6638 nummod 3,C3
R4090 T6641 T6636 punct ;,27
R4091 T6642 T6636 punct [,27
R4092 T6643 T6636 nummod 15,27
R4093 T6644 T6636 punct ",",27
R4094 T6645 T6636 nummod 26,27
R4095 T6646 T6636 punct ",",27
R4096 T6647 T6636 punct ],27
R4097 T6648 T6636 punct ),27
R4098 T6649 T6620 punct ", ",estimated
R4099 T6650 T6620 nsubj we,estimated
R4100 T6651 T6652 mark that,produce
R4101 T6652 T6620 ccomp produce,estimated
R4102 T6653 T6654 det the,lines
R4103 T6654 T6652 nsubj lines,produce
R4104 T6655 T6654 nummod four,lines
R4105 T6656 T6654 amod controllable,lines
R4106 T6657 T6658 amod transgenic,protein
R4107 T6658 T6652 dobj protein,produce
R4108 T6659 T6658 compound APP,protein
R4109 T6660 T6652 prep at,produce
R4110 T6661 T6660 pcomp 10,at
R4111 T6662 T6661 punct -,10
R4112 T6663 T6661 quantmod to,10
R4113 T6664 T6661 advmod 30-fold,10
R4114 T6665 T6661 prep over,10
R4115 T6666 T6667 amod endogenous,levels
R4116 T6667 T6665 pobj levels,over
R4117 T6668 T6669 punct (,S1
R4118 T6669 T6652 parataxis S1,produce
R4119 T6670 T6669 compound Figure,S1
R4120 T6671 T6669 punct ),S1
R4121 T6672 T6620 punct .,estimated